Researchers hope the database, named ImmuneCODE, will help the medical community better understand how T-cells respond to SARS-CoV-2, the virus that causes COVID-19. This availability of immunity data can lead scientists to find the most effective T-cell reaction and use the information to improve COVID-19 diagnostics and treatments.
The database consists of de-identified data from thousands of COVID-19 patients who are ethnically and geographically diverse.
More articles on data analytics:
HHS updates COVID-19 lab test data reporting requirements: 6 details
Apple updates sharing options on COVID-19 app
New York’s Mount Sinai gets Microsoft grant for COVID-19 data center: 4 details
